Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Ulcerative Colitis | Research

Acute idiopathic pancreatitis is associated with more aggressive disease course in Crohn’s disease but not in ulcerative colitis

Authors: Karim T. Osman, Asahi Hoque, Ravi Teja Pasam, Adel Farhoud, Ahmed Abdelfattah, Vishant Ramadorai, Khadija Chaudrey, Randall Pellish

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Purpose

Patients with inflammatory bowel disease (IBD), whether Crohn’s disease (CD) or ulcerative colitis (UC), have an increased risk of acute pancreatitis. The prognostic value of diagnosing acute idiopathic pancreatitis in patients with IBD is not well understood.

Methods

A retrospective review of 56 patients with IBD and acute pancreatitis was conducted in a tertiary center from 2011 to 2020. Aggressive disease course was defined as (i)biologic change, (ii)biologic dose escalation, or (iii)IBD-related surgeries occurring within 1 year of acute pancreatitis diagnosis. Logistic regression modelling identified associations between covariates and an aggressive disease course.

Results

Baseline characteristics between idiopathic pancreatitis and other causes of acute pancreatitis, in both CD and UC cohorts, were similar. Idiopathic pancreatitis was significantly associated with an aggressive disease course in CD (P = 0.04). No confounding factors were associated with an aggressive disease course in CD. Idiopathic pancreatitis, however, was not associated with an aggressive disease course in UC (P = 0.35).

Conclusion

The diagnosis of acute idiopathic pancreatitis may provide a prognostic indicator of a more severe disease course in CD. No such association appears to exist with UC. To the best of our knowledge, this is the first study that identifies an association and possible prognostic value between idiopathic pancreatitis and a more severe disease course in CD. More studies with a larger sample size are needed to validate these findings, further define idiopathic pancreatitis as an extraintestinal manifestation of IBD and elucidate a clinical strategy to optimize care in patients with aggressive CD and idiopathic pancreatitis.
Literature
1.
go back to reference Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018;53(3):305–53.CrossRefPubMedPubMedCentral Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018;53(3):305–53.CrossRefPubMedPubMedCentral
2.
go back to reference Ramos LR, Sachar DB, DiMaio CJ, Colombel JF, Torres J. Inflammatory bowel disease and pancreatitis: a review. J Crohn’s colitis. 2016;10(1):95–104.CrossRef Ramos LR, Sachar DB, DiMaio CJ, Colombel JF, Torres J. Inflammatory bowel disease and pancreatitis: a review. J Crohn’s colitis. 2016;10(1):95–104.CrossRef
3.
go back to reference Blomgren KB, Sundström A, Steineck G, Genell S, Sjöstedt S, Wiholm BE. A swedish case-control network for studies of drug-induced morbidity–acute pancreatitis. Eur J Clin Pharmacol. 2002;58(4):275–83.CrossRefPubMed Blomgren KB, Sundström A, Steineck G, Genell S, Sjöstedt S, Wiholm BE. A swedish case-control network for studies of drug-induced morbidity–acute pancreatitis. Eur J Clin Pharmacol. 2002;58(4):275–83.CrossRefPubMed
4.
go back to reference Rasmussen HH, Fonager K, Sørensen HT, Pedersen L, Dahlerup JF, Steffensen FH. Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A danish 16-year nationwide follow-up study. Scand J Gastroenterol. 1999;34(2):199–201.CrossRefPubMed Rasmussen HH, Fonager K, Sørensen HT, Pedersen L, Dahlerup JF, Steffensen FH. Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A danish 16-year nationwide follow-up study. Scand J Gastroenterol. 1999;34(2):199–201.CrossRefPubMed
5.
go back to reference Munk EM, Pedersen L, Floyd A, Nørgård B, Rasmussen HH, Sørensen HT. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol. 2004;99(5):884–8.CrossRefPubMed Munk EM, Pedersen L, Floyd A, Nørgård B, Rasmussen HH, Sørensen HT. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol. 2004;99(5):884–8.CrossRefPubMed
6.
go back to reference Bermejo F, Lopez-Sanroman A, Taxonera C, Gisbert JP, Pérez-Calle JL, Vera I, et al. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther. 2008;28(5):623–8.CrossRefPubMed Bermejo F, Lopez-Sanroman A, Taxonera C, Gisbert JP, Pérez-Calle JL, Vera I, et al. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther. 2008;28(5):623–8.CrossRefPubMed
7.
go back to reference Okano A, Takakuwa H, Nishio AJIm. Idiopathic pancreatitis may be associated with ulcerative colitis. 2003;42(1):125–6. Okano A, Takakuwa H, Nishio AJIm. Idiopathic pancreatitis may be associated with ulcerative colitis. 2003;42(1):125–6.
8.
go back to reference Sáez J, Martínez J, García C, Griñó P, Pérez-Mateo M. Idiopathic pancreatitis associated with ulcerative colitis. Am J Gastroenterol. 2000;95(10):3004–5.CrossRefPubMed Sáez J, Martínez J, García C, Griñó P, Pérez-Mateo M. Idiopathic pancreatitis associated with ulcerative colitis. Am J Gastroenterol. 2000;95(10):3004–5.CrossRefPubMed
9.
go back to reference Seyrig JA, Jian R, Modigliani R, Golfain D, Florent C, Messing B, et al. Idiopathic pancreatitis associated with inflammatory bowel disease. Dig Dis Sci. 1985;30(12):1121–6.CrossRefPubMed Seyrig JA, Jian R, Modigliani R, Golfain D, Florent C, Messing B, et al. Idiopathic pancreatitis associated with inflammatory bowel disease. Dig Dis Sci. 1985;30(12):1121–6.CrossRefPubMed
10.
go back to reference Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. The American journal of gastroenterology. 2013;108(9):1400-15; 16. Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. The American journal of gastroenterology. 2013;108(9):1400-15; 16.
11.
go back to reference Nitsche C, Maertin S, Scheiber J, Ritter CA, Lerch MM, Mayerle J. Drug-induced pancreatitis. Curr Gastroenterol Rep. 2012;14(2):131–8.CrossRefPubMed Nitsche C, Maertin S, Scheiber J, Ritter CA, Lerch MM, Mayerle J. Drug-induced pancreatitis. Curr Gastroenterol Rep. 2012;14(2):131–8.CrossRefPubMed
12.
go back to reference Yarur AJ, Strobel SG, Deshpande AR, Abreu MT. Predictors of aggressive inflammatory bowel disease. Gastroenterol Hepatol. 2011;7(10):652–9. Yarur AJ, Strobel SG, Deshpande AR, Abreu MT. Predictors of aggressive inflammatory bowel disease. Gastroenterol Hepatol. 2011;7(10):652–9.
13.
go back to reference Concato J, Peduzzi P, Holford TR, Feinstein AR. Importance of events per independent variable in proportional hazards analysis. I. background, goals, and general strategy. J Clin Epidemiol. 1995;48(12):1495–501.CrossRefPubMed Concato J, Peduzzi P, Holford TR, Feinstein AR. Importance of events per independent variable in proportional hazards analysis. I. background, goals, and general strategy. J Clin Epidemiol. 1995;48(12):1495–501.CrossRefPubMed
14.
go back to reference Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48(12):1503–10.CrossRefPubMed Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48(12):1503–10.CrossRefPubMed
15.
go back to reference Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–9.CrossRefPubMed Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–9.CrossRefPubMed
16.
go back to reference Chen Y, Zak Y, Hernandez-Boussard T, Park W, Visser BC. The epidemiology of idiopathic acute pancreatitis, analysis of the nationwide inpatient sample from 1998 to 2007. Pancreas. 2013;42(1):1–5.CrossRefPubMed Chen Y, Zak Y, Hernandez-Boussard T, Park W, Visser BC. The epidemiology of idiopathic acute pancreatitis, analysis of the nationwide inpatient sample from 1998 to 2007. Pancreas. 2013;42(1):1–5.CrossRefPubMed
17.
go back to reference Porges T, Shafat T, Sagy I, Schwarzfuchs D, Rahmani Tzvi-Ran I, Jotkowitz A et al. Clinical Characteristics and Prognosis of Idiopathic Acute Pancreatitis. Rambam Maimonides medical journal. 2021;12(3). Porges T, Shafat T, Sagy I, Schwarzfuchs D, Rahmani Tzvi-Ran I, Jotkowitz A et al. Clinical Characteristics and Prognosis of Idiopathic Acute Pancreatitis. Rambam Maimonides medical journal. 2021;12(3).
18.
go back to reference Ott C, Takses A, Obermeier F, Schnoy E, Müller M. Smoking increases the risk of extraintestinal manifestations in Crohn’s disease. World J Gastroenterol. 2014;20(34):12269–76.CrossRefPubMedPubMedCentral Ott C, Takses A, Obermeier F, Schnoy E, Müller M. Smoking increases the risk of extraintestinal manifestations in Crohn’s disease. World J Gastroenterol. 2014;20(34):12269–76.CrossRefPubMedPubMedCentral
19.
go back to reference Singeap AM, Girleanu I, Diculescu M, Gheorghe L, Ciocîrlan M, Gheorghe C, et al. Risk factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry. J Gastrointest liver diseases: JGLD. 2021;30(3):346–57.CrossRef Singeap AM, Girleanu I, Diculescu M, Gheorghe L, Ciocîrlan M, Gheorghe C, et al. Risk factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry. J Gastrointest liver diseases: JGLD. 2021;30(3):346–57.CrossRef
20.
go back to reference Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21(8):1982–92.CrossRefPubMed Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21(8):1982–92.CrossRefPubMed
21.
go back to reference Khalili H, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, et al. Physical activity and risk of inflammatory bowel disease: prospective study from the nurses. ’ Health Study cohorts. 2013;347:f6633. Khalili H, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, et al. Physical activity and risk of inflammatory bowel disease: prospective study from the nurses. ’ Health Study cohorts. 2013;347:f6633.
22.
go back to reference Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clinic proceedings. 2006;81(11):1462-71. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clinic proceedings. 2006;81(11):1462-71.
23.
go back to reference Ungaro R, Bernstein CN, Gearry R, Hviid A, Kolho KL, Kronman MP, et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014;109(11):1728–38.CrossRefPubMed Ungaro R, Bernstein CN, Gearry R, Hviid A, Kolho KL, Kronman MP, et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014;109(11):1728–38.CrossRefPubMed
24.
go back to reference Li P, Chen K, Mao Z, Luo Y, Xue Y, Zhang Y, et al. Association between Inflammatory Bowel Disease and Pancreatitis: a PRISMA-Compliant systematic review. Gastroenterol Res Pract. 2020;2020:7305241.CrossRefPubMedPubMedCentral Li P, Chen K, Mao Z, Luo Y, Xue Y, Zhang Y, et al. Association between Inflammatory Bowel Disease and Pancreatitis: a PRISMA-Compliant systematic review. Gastroenterol Res Pract. 2020;2020:7305241.CrossRefPubMedPubMedCentral
25.
go back to reference Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat reviews Gastroenterol Hepatol. 2012;9(10):599–608.CrossRef Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat reviews Gastroenterol Hepatol. 2012;9(10):599–608.CrossRef
26.
go back to reference Akshintala VS, Talukdar R, Singh VK, Goggins M. The gut Microbiome in Pancreatic Disease. Clinical gastroenterology and hepatology: the official clinical practice. J Am Gastroenterological Association. 2019;17(2):290–5. Akshintala VS, Talukdar R, Singh VK, Goggins M. The gut Microbiome in Pancreatic Disease. Clinical gastroenterology and hepatology: the official clinical practice. J Am Gastroenterological Association. 2019;17(2):290–5.
27.
go back to reference Memba R, Duggan SN, Ni Chonchubhair HM, Griffin OM, Bashir Y, O’Connor DB, et al. The potential role of gut microbiota in pancreatic disease: a systematic review. Pancreatology: official journal of the International Association of Pancreatology (IAP) [et al]. 2017;17(6):867–74.CrossRefPubMed Memba R, Duggan SN, Ni Chonchubhair HM, Griffin OM, Bashir Y, O’Connor DB, et al. The potential role of gut microbiota in pancreatic disease: a systematic review. Pancreatology: official journal of the International Association of Pancreatology (IAP) [et al]. 2017;17(6):867–74.CrossRefPubMed
28.
go back to reference Newton DF, Macfarlane S, Macfarlane GT. Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms. Antimicrob Agents Chemother. 2013;57(5):2016–25.CrossRefPubMedPubMedCentral Newton DF, Macfarlane S, Macfarlane GT. Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms. Antimicrob Agents Chemother. 2013;57(5):2016–25.CrossRefPubMedPubMedCentral
29.
go back to reference Núñez C, Oliver J, Mendoza JL, Gómez-García M, Piñero A, Taxonera C, et al. MYO9B polymorphisms in patients with inflammatory bowel disease. Gut. 2007;56(9):1321–2.CrossRefPubMedPubMedCentral Núñez C, Oliver J, Mendoza JL, Gómez-García M, Piñero A, Taxonera C, et al. MYO9B polymorphisms in patients with inflammatory bowel disease. Gut. 2007;56(9):1321–2.CrossRefPubMedPubMedCentral
30.
go back to reference Wapenaar MC, Monsuur AJ, van Bodegraven AA, Weersma RK, Bevova MR, Linskens RK, et al. Associations with tight junction genes PARD3 and MAGI2 in dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut. 2008;57(4):463–7.CrossRefPubMed Wapenaar MC, Monsuur AJ, van Bodegraven AA, Weersma RK, Bevova MR, Linskens RK, et al. Associations with tight junction genes PARD3 and MAGI2 in dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut. 2008;57(4):463–7.CrossRefPubMed
31.
go back to reference Tél B, Stubnya B, Gede N, Varjú P, Kiss Z, Márta K, et al. Inflammatory bowel Diseases elevate the risk of developing Acute Pancreatitis: a Meta-analysis. Pancreas. 2020;49(9):1174–81.CrossRefPubMed Tél B, Stubnya B, Gede N, Varjú P, Kiss Z, Márta K, et al. Inflammatory bowel Diseases elevate the risk of developing Acute Pancreatitis: a Meta-analysis. Pancreas. 2020;49(9):1174–81.CrossRefPubMed
32.
go back to reference Weber P, Seibold F, Jenss H. Acute pancreatitis in Crohn’s disease. J Clin Gastroenterol. 1993;17(4):286–91.CrossRefPubMed Weber P, Seibold F, Jenss H. Acute pancreatitis in Crohn’s disease. J Clin Gastroenterol. 1993;17(4):286–91.CrossRefPubMed
Metadata
Title
Acute idiopathic pancreatitis is associated with more aggressive disease course in Crohn’s disease but not in ulcerative colitis
Authors
Karim T. Osman
Asahi Hoque
Ravi Teja Pasam
Adel Farhoud
Ahmed Abdelfattah
Vishant Ramadorai
Khadija Chaudrey
Randall Pellish
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02790-8

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.